Cargando…

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma

The therapeutic options for infantile hemangiomas (IHs) have been greatly altered since the introduction of oral propranolol for successful treatments of IHs. Recently, there is an increase in the application of topical timolol maleate for treating superficial IHs. In the present study, we developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Hai Wei, Liu, Chao, Wang, Xuan, Zhang, Ling, Yuan, Weien, Zheng, Jia Wei, Su, Li Xin, Fan, Xin Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484769/ https://www.ncbi.nlm.nih.gov/pubmed/28702374 http://dx.doi.org/10.3389/fonc.2017.00137

Ejemplares similares

Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
por: Wu, Hai Wei, et al.
Publicado: (2018)

Infantile Hemangiomas with Minimal and Arrested Growth: Clinical Features and Treatment Outcomes with 0.5% Topical Timolol Maleate
por: Bae, Kyung-Nam, et al.
Publicado: (2021)

Topical timolol maleate: An effectual and safe recourse for infantile hemangiomas
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2016)

Timing and Efficacy of 595-nm Pulsed-Dye Laser Combined with 0.5% Timolol Maleate Solution in the Treatment of Superficial Infantile Hemangiomas
por: Shi, Weikang, et al.
Publicado: (2021)

Complicated Infantile Hemangioma Successfully Treated with Topical Timolol 0.5% Solution: A Case Report
por: Borkar, Nitin, et al.
Publicado: (2021)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015)

Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas
por: Tong, Shuang, et al.
Publicado: (2016)

Efficacy Evaluation of 755-nm Long-Pulse Alexandrite Laser Combined with 0.5% Timolol Maleate Eye Drops in the Treatment of Thicker Infantile Hemangioma
por: Wu, Jianming, et al.
Publicado: (2021)

Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study
por: Ge, Jing, et al.
Publicado: (2016)

Dermoscopic Evaluation of Infantile Hemangioma Treated With Topical Timolol
por: Jassi, Rubina, et al.
Publicado: (2020)

A Comfort Survey of Timolol Hemihydrate 0.5% Solution Once or Twice Daily vs Timolol Maleate in Sorbate
por: Stewart, William C, et al.
Publicado: (2013)

Efficacious Healing of Ulcerated Infantile Hemangiomas Using Topical Timolol
por: Chang, Chun-Shin, et al.
Publicado: (2016)

Treatment of superficial infantile hemangiomas with timolol: Evaluation of short-term efficacy and safety in infants
por: YU, LINJUN, et al.
Publicado: (2013)

Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate
por: Roy, Kakoli, et al.
Publicado: (2012)

Sick sinus syndrome associated with topical timolol maleate instillation
por: Walia, Harpreet S., et al.
Publicado: (2011)

Topical Timolol: A Safer Alternative for Complicated and Un-Complicated Infantile Hemangiomas
por: Ambika, Hariharasubramony, et al.
Publicado: (2013)

Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate
por: Singh, Vinod, et al.
Publicado: (2011)

Comment on “Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate”
por: Arunachalam, Cynthia
Publicado: (2013)

Hyperkalemia due to topical timolol for hemangioma
por: Alasmari, Bushra, et al.
Publicado: (2023)

Effects of 0.5% Timolol Maleate Ophthalmic Solution on Heart Rate and Selected Echocardiographic Indices in Apparently Healthy Cats
por: Gunther‐Harrington, C.T., et al.
Publicado: (2016)

Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial
por: Russ, Heloisa Helena, et al.
Publicado: (2013)

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
por: Bell, Nicholas P, et al.
Publicado: (2010)

Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes
por: Singh, Aastha, et al.
Publicado: (2020)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
por: Inoue, Kenji, et al.
Publicado: (2012)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
por: Inoue, Kenji, et al.
Publicado: (2014)

Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
por: Dubey, Akhilesh, et al.
Publicado: (2014)

Propranolol therapy for infantile hemangioma: our experience
por: Zhang, Ling, et al.
Publicado: (2017)

Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review
por: Kardasevic, Mediha, et al.
Publicado: (2021)

Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day
por: Shemesh, Gabi, et al.
Publicado: (2012)

Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily
por: Moisseiev, Elad, et al.
Publicado: (2013)

Estrogen-mediated hemangioma-derived stem cells through estrogen receptor-α for infantile hemangioma
por: Zhang, Ling, et al.
Publicado: (2017)

Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate
por: Jagdale, Swati, et al.
Publicado: (2016)

Abstract: Topical 0.5% Timolol for Chronic Refractory Wounds. an Observational Prospective Study
por: Vestita, Michelangelo, et al.
Publicado: (2017)

Topical timolol maleate 0.5% after fractional carbon dioxide laser versus fractional carbon dioxide laser alone in treatment of acne scars: split face comparative study
por: Hawwas, Aya Reda Mohamed, et al.
Publicado: (2023)

Management of infantile hemangiomas: Recent advances
por: Xu, Wei, et al.
Publicado: (2022)

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure
por: Lee, Anne J, et al.
Publicado: (2008)

Efficacy of Combined Topical Timolol and Oral Propranolol for Treating Infantile Hemangioma: A Meta-Analysis of Randomized Controlled Trials
por: Qiao, Junbo, et al.
Publicado: (2020)

Bilateral Choroidal Detachment Induced by Unilateral Application of a Fixed Combination of Topical Timolol Maleate and Brinzolamide
por: DONMEZ, Oya, et al.
Publicado: (2016)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
por: Schnober, Dietmar, et al.
Publicado: (2015)

Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
por: Inoue, Kenji, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5sj4g5nu0egip13ke4q358b19q